Literature DB >> 18612813

Parkin expression profile in dopamine d3 receptor knock-out mice brains.

Velia D'Agata1, Adriana Tiralongo, Alessandro Castorina, Gian Marco Leggio, Vincenzo Micale, Maria Luisa Carnazza, Filippo Drago.   

Abstract

Patients affected by autosomic recessive juvenile parkinsonism (ARJP) exhibit parkin gene mutations with brain decrease in dopamine D2/D3 binding sites. To date, there are no data indicating whether the reduction in dopamine D3 receptors (DRD3) may be associated with the expression of specific parkin variants. In the present study we investigated parkin expression profile in DRD3 knock-out mice brains. RT-PCR analysis was performed to assess qualitative changes in parkin isoforms' distribution pattern and in exons' expression both in wild type controls and dopamine D3 receptor's knock-out mice. Real-time PCR was performed to quantify single exons mRNA. Results demonstrated that exons 1, 2, 4, 6, 7, 8, were more expressed in wild type compared to dopamine D3 receptor KO mice brains while some other (3, 9, 10) were lower expressed. The expression levels of exons 5, 11 and 12 did not change in both animal groups. Our analysis was confirmed by western blot, which showed that parkin protein levels were influenced by the absence of DRD3.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18612813     DOI: 10.1007/s11064-008-9781-y

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  28 in total

1.  Parkin expression in the adult mouse brain.

Authors:  C C Stichel; M Augustin; K Kühn; X R Zhu; P Engels; C Ullmer; H Lübbert
Journal:  Eur J Neurosci       Date:  2000-12       Impact factor: 3.386

2.  Functional impairment in protein kinase C by RACK1 (receptor for activated C kinase 1) deficiency in aged rat brain cortex.

Authors:  A Pascale; I Fortino; S Govoni; M Trabucchi; W C Wetsel; F Battaini
Journal:  J Neurochem       Date:  1996-12       Impact factor: 5.372

3.  Alterations in the solubility and intracellular localization of parkin by several familial Parkinson's disease-linked point mutations.

Authors:  Cheng Wang; Jeanne M M Tan; Michelle W L Ho; Norazean Zaiden; Siew Heng Wong; Constance L C Chew; Pei Woon Eng; Tit Meng Lim; Ted M Dawson; Kah Leong Lim
Journal:  J Neurochem       Date:  2005-04       Impact factor: 5.372

4.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.

Authors:  T Kitada; S Asakawa; N Hattori; H Matsumine; Y Yamamura; S Minoshima; M Yokochi; Y Mizuno; N Shimizu
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

5.  Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.

Authors:  Sathya R Sriram; Xiaojie Li; Han Seok Ko; Kenny K K Chung; Esther Wong; Kah Leong Lim; Valina L Dawson; Ted M Dawson
Journal:  Hum Mol Genet       Date:  2005-07-27       Impact factor: 6.150

6.  Differential expression of the parkin gene in the human brain and peripheral leukocytes.

Authors:  Y Sunada; F Saito; K Matsumura; T Shimizu
Journal:  Neurosci Lett       Date:  1998-10-02       Impact factor: 3.046

Review 7.  Molecular diversity of the dopamine receptors.

Authors:  O Civelli; J R Bunzow; D K Grandy
Journal:  Annu Rev Pharmacol Toxicol       Date:  1993       Impact factor: 13.820

Review 8.  Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs.

Authors:  J N Joyce
Journal:  Pharmacol Ther       Date:  2001 May-Jun       Impact factor: 12.310

9.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.

Authors:  H Shimura; N Hattori; S i Kubo; Y Mizuno; S Asakawa; S Minoshima; N Shimizu; K Iwai; T Chiba; K Tanaka; T Suzuki
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

Review 10.  Parkin's substrates and the pathways leading to neuronal damage.

Authors:  Mark R Cookson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 4.103

View more
  2 in total

Review 1.  Dopamine receptors and Parkinson's disease.

Authors:  Shin Hisahara; Shun Shimohama
Journal:  Int J Med Chem       Date:  2011-06-13

2.  Dopamine receptor 3 might be an essential molecule in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.

Authors:  Yan Chen; Ying-yin Ni; Jie Liu; Jia-wei Lu; Fang Wang; Xiao-lin Wu; Ming-min Gu; Zhen-yu Lu; Zhu-gang Wang; Zhi-hua Ren
Journal:  BMC Neurosci       Date:  2013-07-31       Impact factor: 3.288

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.